AVDL (Avadel Pharmaceuticals plc) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Graphic logo of avadel.com (AVDL)

Avadel Pharmaceuticals (AVDL) relies on an elite staff of neurologists and robust financial support for its research. This historical EV/EBITDA chart captures the current metric of 251.84, assessing the business value inclusive of debt. Orphan drug status helps the company successfully compete against the long-standing market leader. Patent protection for its unique nighttime medication ensures the issuer maintains high margins within the US healthcare segment.

AVDL (Avadel Pharmaceuticals PLC) Company Value to EBITDA history from 11/23/2025 to 02/28/2026

Comprehensive metric breakdowns and analytics for avadel.com (AVDL)

- market price and analyst price targets:
Price Chart Avadel Pharma|AVDL - Forecast Levels Chart
- business market valuation indicators:
Market Value Avadel Corp|AVDL - Company Buyout Price
- book value of equity indicators:
Accounting Value per Share Avadel Pharmaceuticals|AVDL - Total Stockholders' Equity|Market Capitalization to Book Value Ratio avadel.com|AVDL - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Avadel Pharmaceuticals|AVDL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Avadel Pharmaceuticals plc|AVDL - Company Cumulative Debt|Debts to Book Capitalization Avadel Corp|AVDL - Company Long-Term Debts|Company Current Liabilities Avadel Pharmaceuticals|Quick Ratio avadel.com
- net income and valuation multiples indicators:
AVDL - Net Profit|Projected Future Earnings Avadel Pharmaceuticals|AVDL - Price to Earnings Multiple|Forward P/E Multiple Avadel Pharmaceuticals|AVDL - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avadel Corp|AVDL - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Avadel Pharmaceuticals|AVDL - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months avadel.com|AVDL - Earnings per share trend in current year|Earnings growth forecast for next year Avadel Pharmaceuticals
Initial company analysis:Avadel Pharma AVDL
Product sample of Avadel Pharmaceuticals plc

The EV/EBITDA multiple assesses the total value of Avadel Pharmaceuticals (AVDL) assets relative to its operating profit before interest and taxes, allowing for the determination of the business's overvaluation level. Analysis of the EV/EBITDA chart confirms the investment attractiveness of Avadel Pharmaceuticals (AVDL), as the stable cash flow from the sale of its narcolepsy drug provides a sustainable foundation for capitalization and operating margin growth.

Competitors of Avadel Pharmaceuticals

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alkermes Inc. ALKS|ATAI (atai) - Company Value to Operating Income Before Depreciation Ratio|GHRS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio mindmed.co MNMD|CMPS (COMPASS Pathways) - Enterprise Value to EBITDA Ratio|Company Value to EBITDA LB Pharmaceuticals, Inc. (LBRX)|DRUG (Bright Minds Biosciences Inc) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Vanda (VNDA)|EV/EBITDA Multiple CYBN|ANRO (altoneuroscience.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NRx Pharmaceuticals, Inc. NRXP|Cingulate Inc (CING) - Company Value to EBITDA|Silo Pharma - EV/EBITDA Multiple|CPHI - EV/EBITDA Multiple|CMND (Clearmind Medicine Inc.) - Enterprise Value to EBITDA Ratio|PBM (pacificbayminerals.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SPRC (SciSparc) - EV/EBITDA Multiple|EV/EBITDA Multiple Seelos Therapeutics Inc.|EV/EBITDA Multiple VRPX|Karuna Pharma - Enterprise Value to Operating Income Before Depreciation